{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:03:48Z","timestamp":1789632228774,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007131","name":"Changzhou Science and Technology Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007131","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Photodiagnosis and Photodynamic Therapy"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.pdpdt.2026.105344","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T16:58:38Z","timestamp":1767891518000},"page":"105344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The serum level of leucine-rich alpha-2 glycoprotein to differentiate between ischemic and non-ischemic retinal vein occlusion"],"prefix":"10.1016","volume":"58","author":[{"given":"Shengqun","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xincheng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3545-9869","authenticated-orcid":false,"given":"Yanwen","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pdpdt.2026.105344_bib0001","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1080\/17512433.2023.2277882","article-title":"Novel pharmaceuticals for the management of retinal vein occlusion and linked disorders","volume":"16","author":"Driban","year":"2023","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.pdpdt.2026.105344_bib0002","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1136\/bjophthalmol-2020-315836","article-title":"Real world evidence on 5661 patients treated for macular oedema secondary to branch retinal vein occlusion with intravitreal anti-vascular endothelial growth factor, intravitreal dexamethasone or macular laser","volume":"105","author":"Gale","year":"2021","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2026.105344_bib0003","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1167\/iovs.65.2.6","article-title":"Central and Peripheral Changes in Retinal Vein Occlusion and Fellow Eyes in Ultra-Widefield Optical Coherence Tomography Angiography","volume":"65","author":"Zhao","year":"2024","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.pdpdt.2026.105344_bib0004","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ajo.2019.03.029","article-title":"Loss of Peak Vision in Retinal Vein Occlusion Patients Treated for Macular Edema","volume":"205","author":"Iftikhar","year":"2019","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2026.105344_bib0005","article-title":"Review: The Development of Risk Factors and Cytokines in Retinal Vein Occlusion","volume":"9","author":"Tang","year":"2022","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.pdpdt.2026.105344_bib0006","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nature12345","article-title":"LRG1 promotes angiogenesis by modulating endothelial TGF-beta signalling","volume":"499","author":"Wang","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.pdpdt.2026.105344_bib0007","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/aos.13633","article-title":"Elevated plasma and vitreous levels of leucine-rich-alpha2-glycoprotein are associated with diabetic retinopathy progression","volume":"97","author":"Chen","year":"2019","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.pdpdt.2026.105344_bib0008","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168879","article-title":"LRG1 Expression Is Elevated in the Eyes of Patients with Neovascular Age-Related Macular Degeneration","volume":"22","author":"Mundo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pdpdt.2026.105344_bib0009","article-title":"Retinal ischemic diseases and promising therapeutic molecular targets","author":"Lee","year":"2024","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.pdpdt.2026.105344_bib0010","first-page":"501","article-title":"Aqueous levels of erythropoietin in acute retinal vein occlusion with macular edema","volume":"7","author":"Shin","year":"2014","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2026.105344_bib0011","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12551-014-0158-y","article-title":"The role of TGFbeta1 and LRG1 in cardiac remodelling and heart failure","volume":"7","author":"Song","year":"2015","journal-title":"Biophys. Rev."},{"key":"10.1016\/j.pdpdt.2026.105344_bib0012","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jdiacomp.2019.05.021","article-title":"Leucine-rich alpha-2-glycoprotein predicts proliferative diabetic retinopathy in type 2 diabetes","volume":"33","author":"Zhang","year":"2019","journal-title":"J. Diabetes Complications"},{"key":"10.1016\/j.pdpdt.2026.105344_bib0013","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1159\/000532042","article-title":"The Leucine-Rich alpha2-Glycoprotein-1 Levels in Patients with Multiple Myeloma","volume":"46","author":"Kacmaz","year":"2023","journal-title":"Oncol. Res. Treat."},{"key":"10.1016\/j.pdpdt.2026.105344_bib0014","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1111\/cas.13329","article-title":"Overexpression of leucine-rich alpha2-glycoprotein-1 is a prognostic marker and enhances tumor migration in gastric cancer","volume":"108","author":"Yamamoto","year":"2017","journal-title":"Cancer Sci."},{"key":"10.1016\/j.pdpdt.2026.105344_bib0015","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12894-024-01481-0","article-title":"Increased level of serum leucine-rich-alpha-2-glycoprotein 1 in patients with clear cell renal cell carcinoma","volume":"24","author":"Nakanishi","year":"2024","journal-title":"BMC. Urol."},{"key":"10.1016\/j.pdpdt.2026.105344_bib0016","article-title":"LRG1 promotes atherosclerosis by inducing macrophage M1-like polarization","volume":"121","author":"Wang","year":"2024","journal-title":"Proc. Natl. Acad. Sci. u S. a"},{"key":"10.1016\/j.pdpdt.2026.105344_bib0017","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1210\/jc.2014-3855","article-title":"Elevation of a novel angiogenic factor, leucine-rich-alpha2-glycoprotein (LRG1), is associated with arterial stiffness, endothelial dysfunction, and peripheral arterial disease in patients with type 2 diabetes","volume":"100","author":"Pek","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.pdpdt.2026.105344_bib0018","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1136\/bjophthalmol-2019-315358","article-title":"Higher aqueous levels of matrix metalloproteinases indicated visual impairment in patients with retina vein occlusion after anti-VEGF therapy","volume":"105","author":"Luo","year":"2021","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2026.105344_bib0019","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/archopht.1982.01030040110020","article-title":"Histopathologic study of nine branch retinal vein occlusions","volume":"100","author":"Frangieh","year":"1982","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2026.105344_bib0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/IIO.0b013e3181a8db88","article-title":"Retinal vascular occlusion syndromes","volume":"49","author":"Haymore","year":"2009","journal-title":"Int. Ophthalmol. Clin."},{"key":"10.1016\/j.pdpdt.2026.105344_bib0021","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","article-title":"VEGF in Signaling and Disease: Beyond Discovery and Development","volume":"176","author":"Apte","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.pdpdt.2026.105344_bib0022","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhlen","year":"2015","journal-title":"Science (1979)"},{"key":"10.1016\/j.pdpdt.2026.105344_bib0023","first-page":"101","article-title":"Oxygen-induced retinopathy in the mouse","volume":"35","author":"Smith","year":"1994","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.pdpdt.2026.105344_bib0024","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12081821","article-title":"Diagnostic Performance of Serum Leucine-Rich Alpha-2-Glycoprotein 1 in Pediatric Acute Appendicitis: A Prospective Validation Study","volume":"12","author":"Arredondo Montero","year":"2024","journal-title":"Biomedicines."},{"key":"10.1016\/j.pdpdt.2026.105344_bib0025","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1007\/s00404-024-07434-0","article-title":"High serum levels of leucine-rich alpha-2 glycoprotein 1 (LRG-1) are associated with poor survival in patients with early breast cancer","volume":"309","author":"Gobel","year":"2024","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.pdpdt.2026.105344_bib0026","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8825374","article-title":"Evaluation of Serum Leucine-Rich Alpha-2 Glycoprotein as a New Inflammatory Biomarker of Inflammatory Bowel Disease","volume":"2021","author":"Yoshimura","year":"2021","journal-title":"Mediators. Inflamm."},{"key":"10.1016\/j.pdpdt.2026.105344_bib0027","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jim.2008.03.004","article-title":"ELISA for human serum leucine-rich alpha-2-glycoprotein-1 employing cytochrome c as the capturing ligand","volume":"336","author":"Weivoda","year":"2008","journal-title":"J. Immunol. Methods"}],"container-title":["Photodiagnosis and Photodynamic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100026000116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100026000116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:18:54Z","timestamp":1789629534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1572100026000116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":27,"alternative-id":["S1572100026000116"],"URL":"https:\/\/doi.org\/10.1016\/j.pdpdt.2026.105344","relation":{},"ISSN":["1572-1000"],"issn-type":[{"value":"1572-1000","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The serum level of leucine-rich alpha-2 glycoprotein to differentiate between ischemic and non-ischemic retinal vein occlusion","name":"articletitle","label":"Article Title"},{"value":"Photodiagnosis and Photodynamic Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pdpdt.2026.105344","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105344"}}